APhA aims to add value to R.Ph. license

Technology, such as continuous glucose monitors, changes the way patients are treated, but more work needs to be done for racial, ethnic, and socioeconomic disparities.

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

This year’s conference is taking place from April 10 to 12 in Austin, Texas.

In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.

Type 1 diabetes can cause long-term complications, including the development of autoimmune diseases.

Technological evolution promises to enhance patient care, reduce errors, and provide intelligent support that augments human expertise rather than replacing it.